Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-10 21:00:16 ET
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call March 10, 2026 4:30 PM EDT
Company Participants
Punit Dhillon - President, CEO, Principal Accounting Officer & Director
Christopher Twitty - Chief Scientific Officer
Tu Diep - Chief Operating Officer
...
Read the full article on Seeking Alpha
For further details see:
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript
Skye Bioscience Inc Com
NASDAQ: SKYE
SKYE Trading
1.74% G/L:
$0.7122 Last:
85,186 Volume:
$0.7346 Open:
SKYE Latest News
April 02, 2026 07:00:00 am
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
March 10, 2026 04:01:00 pm
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
SKYE Stock Data
$23,264,099
19,202,419
2.95%
18
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
